0.59
0.02 (3.51%)
0.02 (3.51%)
Upgrade to Real-Time
Market Closed
Low
0.41
High
0.83
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Antibe Therapeutics Inc | ATE | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.58 | 0.57 | 0.60 | 0.59 | 0.57 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
16 | 15,400 | - | 0.41 - 0.83 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:23:31 | 500 | $ 0.59 | CAD |
Antibe Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 30.76M | - | - | $ 2.73M | $ 0.00 | -0.50 | -1.40 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
31.10k | $ - | - | 0.00 | - |
Antibe Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.61 | 0.61 | 0.55 | 0.5635777 | 26,313 | -0.02 | -3.28% |
1 Month | 0.44 | 0.69 | 0.44 | 0.5841754 | 28,347 | 0.15 | 34.09% |
3 Months | 0.52 | 0.69 | 0.41 | 0.5168412 | 30,185 | 0.07 | 13.46% |
6 Months | 0.60 | 0.71 | 0.41 | 0.552961 | 24,187 | -0.01 | -1.67% |
1 Year | 0.67 | 0.83 | 0.41 | 0.6291564 | 27,116 | -0.08 | -11.94% |
3 Years | 0.415 | 7.52 | 0.375 | 2.18 | 132,877 | 0.175 | 42.17% |
5 Years | 0.415 | 7.52 | 0.375 | 2.18 | 132,877 | 0.175 | 42.17% |
Antibe Therapeutics Description
Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. |